… but did not have the time to…
I would like to have blogged about this thought provoking excerpt from Russell Banks’ The Darling on the difference between empathy and sympathy.
“What was ethically and even practically wrong with having empathy towards the other? For a long time, I answered, Nothing. Nothing at all. It’s good politics. I see a blind man about to cross a street and think, He can’t see the whizzing traffic, he needs me to see it for him, to take his arm and escort him over to …

A response to IRIN/PlusNews list of six potholes in the road to significantly increasing HIV treatment coverage in Africa.
1. Cost:
The Joint UN Programme on HIV/AIDS (UNAIDS) has estimated that US$ 28 billion to US$ 50 billion would be needed globally every year from 2010 to 2015 in order to progressively reach universal access targets for HIV/AIDS by 2015. One-third of this will contribute towards the cost of the drugs.
The figure may sound “staggering” but it needs to be put in perspective with a few other figures such as:

The cost of …

Can we, and should we, pay people to change their behaviour to stop the spread of the HIV virus which causes AIDS? When it comes to HIV prevention, there is nowadays no limit to the “we need more options” motto and that’s what two World Bank studies conducted in Malawi and Tanzania showed.
In an experiment conducted in Malawi, girls aged 13 to 22 and their parents received as much as $15 each month if the girls attended school regularly, HIV Prevalence was 60% lower among girls receiving cash payments.Though this …

PITTSBURGH (PA, USA) – Women represent more than half of those infected with HIV worldwide. In sub-Saharan Africa the figure reaches 60% and such a high rate of infection occurs in a context where women’s fertility rate is also high compared to the developed world. Pregnancy is therefore a critical issue when reseearching and responding to the HIV epidemics but little is known about the impact of pregnancy on HIV transmission and results are contradictory.
However, for the first time, a research team has investigated in a large study the impact …

HAART for HIV Prevention, an Overview
(reproduced with permission)

Despite the interesting results of an HIV vaccine trial in Thailand (RV144), HIV prevention is still limited to a small number of options many of which are not bullet-proof. Biomedical interventions based on vaccines and microbicides are still a long shot away. Conversely, treatment is working well in bringing HIV-infected people back to a normal life and potentially reducing the risk of HIV transmission by reducing their viral load. The use of antiretroviral drugs as a means …